+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Human Microbiome Market Intelligence Report - Global Forecast to 2027

  • PDF Icon

    Report

  • 119 Pages
  • July 2022
  • Region: Global
  • Think Market Intelligence
  • ID: 5624078
UP TO OFF until Dec 31st 2022
The Global Human Microbiome Market is projected to reach USD 3,724.81 million by 2027 from USD 1,053.28 million in 2021, at a CAGR of 23.43% during the forecast period.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available.

In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

  • The Americas Human Microbiome Market size was estimated at USD 421.10 million in 2021 and expected to reach USD 516.80 million in 2022, at a CAGR of 23.48% to reach USD 1,492.84 million by 2027.
  • The Asia-Pacific Human Microbiome Market size was estimated at USD 268.32 million in 2021 and expected to reach USD 332.21 million in 2022, at a CAGR of 23.83% to reach USD 967.77 million by 2027.
  • The Europe, Middle East & Africa Human Microbiome Market size was estimated at USD 363.85 million in 2021 and expected to reach USD 442.02 million in 2022, at a CAGR of 23.06% to reach USD 1,264.18 million by 2027.

Market Segmentation & Coverage:

The report on human microbiome identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.

This research report categorizes the human microbiome to forecast the revenues and analyze the trends in each of the following sub-markets:

Disease:

  • Acute Diarrhea
  • Autoimmune Disorders
  • Cancer
  • Diabetes
  • Mental Disorders
  • Obesity

Technology:

  • 16s rRNA Sequencing
  • Cell Culture Technology
  • Computational Tools
  • High-Throughput Technology
  • Metagenomic Sequencing
  • Omics Technology

Product:

  • Diagnostic Devices
  • Drugs
  • Foods
  • Prebiotic & Probiotics

Therapeutic Area:

  • Gastrointestinal Disorders
  • Metabolic Disorders
  • Skin Disorders
  • Women’s Health

Application:

  • Diagnostics
  • Therapeutics

Region:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Connecticut
      • Florida
      • Illinois
      • Maryland
      • Minnesota
      • New Jersey
      • New York
      • Ohio
      • Pennsylvania
      • Texas
      • Washington
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
  • Europe, Middle East & Africa
    • France
    • Germany
    • Italy
    • Netherlands
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • United Arab Emirates
    • United Kingdom

Company Usability Profiles:

  • 4D pharma PLC
  • AOBiome, LLC
  • Astarte Medical Partners, Inc
  • Axial Therapeutics, Inc.
  • DuPont de Nemours, Inc.
  • Enterome Bioscience
  • Evelo Biosciences, Inc.
  • Exeliom Biosciences SAS
  • Ferring B.V.
  • Finch Therapeutics Group, Inc.
  • Intralytix, Inc.
  • Locus Biosciences, Inc.
  • Merck and Co. Inc.
  • Metabiomics Corporation
  • Osel Inc.
  • Second Genome, Inc.
  • Seres Therapeutics, Inc.
  • Synlogic, Inc.
  • Synthetic Biologics, Inc.
  • Vedanta Biosciences, Inc.
  • Yakult Honsha Co., Ltd.
Frequently Asked Questions about the Global Human Microbiome Market

What is the estimated value of the Global Human Microbiome Market?

The Global Human Microbiome Market was estimated to be valued at $1053.28 Million in 2021.

What is the growth rate of the Global Human Microbiome Market?

The growth rate of the Global Human Microbiome Market is 23.4%, with an estimated value of $3724.81 Million by 2027.

What is the forecasted size of the Global Human Microbiome Market?

The Global Human Microbiome Market is estimated to be worth $3724.81 Million by 2027.

Who are the key companies in the Global Human Microbiome Market?

Key companies in the Global Human Microbiome Market include 4D pharma PLC, AOBiome, LLC, Astarte Medical Partners, Inc, Axial Therapeutics, Inc., DuPont de Nemours, Inc., Enterome Bioscience, Evelo Biosciences, Inc., Exeliom Biosciences SAS and Finch Therapeutics Group, Inc..

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Market Overview
4. Human Microbiome Market, by Disease
4.1. Introduction
4.2. Acute Diarrhea
4.3. Autoimmune Disorders
4.4. Cancer
4.5. Diabetes
4.6. Mental Disorders
4.7. Obesity
5. Human Microbiome Market, by Technology
5.1. Introduction
5.2. 16s rRNA Sequencing
5.3. Cell Culture Technology
5.4. Computational Tools
5.5. High-Throughput Technology
5.6. Metagenomic Sequencing
5.7. Omics Technology
6. Human Microbiome Market, by Product
6.1. Introduction
6.2. Diagnostic Devices
6.3. Drugs
6.4. Foods
6.5. Prebiotic & Probiotics
7. Human Microbiome Market, by Therapeutic Area
7.1. Introduction
7.2. Gastrointestinal Disorders
7.3. Metabolic Disorders
7.4. Skin Disorders
7.5. Women’s Health
8. Human Microbiome Market, by Application
8.1. Introduction
8.2. Diagnostics
8.3. Therapeutics
9. Company Usability Profiles
9.1. 4D pharma PLC
9.2. AOBiome, LLC
9.3. Astarte Medical Partners, Inc
9.4. Axial Therapeutics, Inc.
9.5. DuPont de Nemours, Inc.
9.6. Enterome Bioscience
9.7. Evelo Biosciences, Inc.
9.8. Exeliom Biosciences SAS
9.9. Ferring B.V.
9.10. Finch Therapeutics Group, Inc.
9.11. Intralytix, Inc.
9.12. Locus Biosciences, Inc.
9.13. Merck and Co. Inc.
9.14. Metabiomics Corporation
9.15. Osel Inc.
9.16. Second Genome, Inc.
9.17. Seres Therapeutics, Inc.
9.18. Synlogic, Inc.
9.19. Synthetic Biologics, Inc.
9.20. Vedanta Biosciences, Inc.
9.21. Yakult Honsha Co., Ltd.
10. Appendix
10.1. Discussion Guide
10.2. License & Pricing
List of Figures
Figure 1. Global Human Microbiome Market: Research Process
Figure 2. Global Human Microbiome Market Size, 2019-2027 (USD Million)
Figure 3. Global Human Microbiome Market Size, by Region, 2021 Vs 2027 (%)
Figure 4. Global Human Microbiome Market Size, by Region, 2021 Vs 2027 (USD Million)
Figure 5. Global Human Microbiome Market Competitive Strategic Window, by Region, 2027
Figure 6. Global Human Microbiome Market Size, by Country, 2021 Vs 2027 (%)
Figure 7. Global Human Microbiome Market Size, by Country, 2021 Vs 2027 (USD Million)
Figure 8. Global Human Microbiome Market Competitive Strategic Window, by Country, 2027
Figure 9. Global Human Microbiome Market Size, by Disease, 2021 Vs 2027 (%)
Figure 10. Global Human Microbiome Market Size, by Disease, 2021 Vs 2027 (USD Million)
Figure 11. Global Human Microbiome Market Competitive Strategic Window, by Disease, 2027
Figure 12. Global Human Microbiome Market Size, by Acute Diarrhea, 2019-2027 (USD Million)
Figure 13. Global Human Microbiome Market Size, by Autoimmune Disorders, 2019-2027 (USD Million)
Figure 14. Global Human Microbiome Market Size, by Cancer, 2019-2027 (USD Million)
Figure 15. Global Human Microbiome Market Size, by Diabetes, 2019-2027 (USD Million)
Figure 16. Global Human Microbiome Market Size, by Mental Disorders, 2019-2027 (USD Million)
Figure 17. Global Human Microbiome Market Size, by Obesity, 2019-2027 (USD Million)
Figure 18. Global Human Microbiome Market Size, by Technology, 2021 Vs 2027 (%)
Figure 19. Global Human Microbiome Market Size, by Technology, 2021 Vs 2027 (USD Million)
Figure 20. Global Human Microbiome Market Competitive Strategic Window, by Technology, 2027
Figure 21. Global Human Microbiome Market Size, by 16S Rrna Sequencing, 2019-2027 (USD Million)
Figure 22. Global Human Microbiome Market Size, by Cell Culture Technology, 2019-2027 (USD Million)
Figure 23. Global Human Microbiome Market Size, by Computational Tools, 2019-2027 (USD Million)
Figure 24. Global Human Microbiome Market Size, by High-Throughput Technology, 2019-2027 (USD Million)
Figure 25. Global Human Microbiome Market Size, by Metagenomic Sequencing, 2019-2027 (USD Million)
Figure 26. Global Human Microbiome Market Size, by Omics Technology, 2019-2027 (USD Million)
Figure 27. Global Human Microbiome Market Size, by Product, 2021 Vs 2027 (%)
Figure 28. Global Human Microbiome Market Size, by Product, 2021 Vs 2027 (USD Million)
Figure 29. Global Human Microbiome Market Competitive Strategic Window, by Product, 2027
Figure 30. Global Human Microbiome Market Size, by Diagnostic Devices, 2019-2027 (USD Million)
Figure 31. Global Human Microbiome Market Size, by Drugs, 2019-2027 (USD Million)
Figure 32. Global Human Microbiome Market Size, by Foods, 2019-2027 (USD Million)
Figure 33. Global Human Microbiome Market Size, by Prebiotic & Probiotics, 2019-2027 (USD Million)
Figure 34. Global Human Microbiome Market Size, by Therapeutic Area, 2021 Vs 2027 (%)
Figure 35. Global Human Microbiome Market Size, by Therapeutic Area, 2021 Vs 2027 (USD Million)
Figure 36. Global Human Microbiome Market Competitive Strategic Window, by Therapeutic Area, 2027
Figure 37. Global Human Microbiome Market Size, by Gastrointestinal Disorders, 2019-2027 (USD Million)
Figure 38. Global Human Microbiome Market Size, by Metabolic Disorders, 2019-2027 (USD Million)
Figure 39. Global Human Microbiome Market Size, by Skin Disorders, 2019-2027 (USD Million)
Figure 40. Global Human Microbiome Market Size, by Women’S Health, 2019-2027 (USD Million)
Figure 41. Global Human Microbiome Market Size, by Application, 2021 Vs 2027 (%)
Figure 42. Global Human Microbiome Market Size, by Application, 2021 Vs 2027 (USD Million)
Figure 43. Global Human Microbiome Market Competitive Strategic Window, by Application, 2027
Figure 44. Global Human Microbiome Market Size, by Diagnostics, 2019-2027 (USD Million)
Figure 45. Global Human Microbiome Market Size, by Therapeutics, 2019-2027 (USD Million)
List of Tables
Table 1. Global Human Microbiome Market Segmentation & Coverage
Table 2. United States Dollar Exchange Rate, 2019-2021
Table 3. Global Human Microbiome Market Size, 2019-2027 (USD Million)
Table 4. Global Human Microbiome Market Size, by Region, 2019-2027 (USD Million)
Table 5. Global Human Microbiome Market Size, by Country, 2019-2027 (USD Million)
Table 6. Global Human Microbiome Market Size, by Disease, 2019-2027 (USD Million)
Table 7. Global Human Microbiome Market Size, by Acute Diarrhea, 2019-2027 (USD Million)
Table 8. Global Human Microbiome Market Size, by Acute Diarrhea, by Region, 2019-2027 (USD Million)
Table 9. Global Human Microbiome Market Size, by Acute Diarrhea, by Region, 2019-2027 (USD Million)
Table 10. Global Human Microbiome Market Size, by Autoimmune Disorders, 2019-2027 (USD Million)
Table 11. Global Human Microbiome Market Size, by Autoimmune Disorders, by Region, 2019-2027 (USD Million)
Table 12. Global Human Microbiome Market Size, by Autoimmune Disorders, by Region, 2019-2027 (USD Million)
Table 13. Global Human Microbiome Market Size, by Cancer, 2019-2027 (USD Million)
Table 14. Global Human Microbiome Market Size, by Cancer, by Region, 2019-2027 (USD Million)
Table 15. Global Human Microbiome Market Size, by Cancer, by Region, 2019-2027 (USD Million)
Table 16. Global Human Microbiome Market Size, by Diabetes, 2019-2027 (USD Million)
Table 17. Global Human Microbiome Market Size, by Diabetes, by Region, 2019-2027 (USD Million)
Table 18. Global Human Microbiome Market Size, by Diabetes, by Region, 2019-2027 (USD Million)
Table 19. Global Human Microbiome Market Size, by Mental Disorders, 2019-2027 (USD Million)
Table 20. Global Human Microbiome Market Size, by Mental Disorders, by Region, 2019-2027 (USD Million)
Table 21. Global Human Microbiome Market Size, by Mental Disorders, by Region, 2019-2027 (USD Million)
Table 22. Global Human Microbiome Market Size, by Obesity, 2019-2027 (USD Million)
Table 23. Global Human Microbiome Market Size, by Obesity, by Region, 2019-2027 (USD Million)
Table 24. Global Human Microbiome Market Size, by Obesity, by Region, 2019-2027 (USD Million)
Table 25. Global Human Microbiome Market Size, by Technology, 2019-2027 (USD Million)
Table 26. Global Human Microbiome Market Size, by 16S Rrna Sequencing, 2019-2027 (USD Million)
Table 27. Global Human Microbiome Market Size, by 16S Rrna Sequencing, by Region, 2019-2027 (USD Million)
Table 28. Global Human Microbiome Market Size, by 16S Rrna Sequencing, by Region, 2019-2027 (USD Million)
Table 29. Global Human Microbiome Market Size, by Cell Culture Technology, 2019-2027 (USD Million)
Table 30. Global Human Microbiome Market Size, by Cell Culture Technology, by Region, 2019-2027 (USD Million)
Table 31. Global Human Microbiome Market Size, by Cell Culture Technology, by Region, 2019-2027 (USD Million)
Table 32. Global Human Microbiome Market Size, by Computational Tools, 2019-2027 (USD Million)
Table 33. Global Human Microbiome Market Size, by Computational Tools, by Region, 2019-2027 (USD Million)
Table 34. Global Human Microbiome Market Size, by Computational Tools, by Region, 2019-2027 (USD Million)
Table 35. Global Human Microbiome Market Size, by High-Throughput Technology, 2019-2027 (USD Million)
Table 36. Global Human Microbiome Market Size, by High-Throughput Technology, by Region, 2019-2027 (USD Million)
Table 37. Global Human Microbiome Market Size, by High-Throughput Technology, by Region, 2019-2027 (USD Million)
Table 38. Global Human Microbiome Market Size, by Metagenomic Sequencing, 2019-2027 (USD Million)
Table 39. Global Human Microbiome Market Size, by Metagenomic Sequencing, by Region, 2019-2027 (USD Million)
Table 40. Global Human Microbiome Market Size, by Metagenomic Sequencing, by Region, 2019-2027 (USD Million)
Table 41. Global Human Microbiome Market Size, by Omics Technology, 2019-2027 (USD Million)
Table 42. Global Human Microbiome Market Size, by Omics Technology, by Region, 2019-2027 (USD Million)
Table 43. Global Human Microbiome Market Size, by Omics Technology, by Region, 2019-2027 (USD Million)
Table 44. Global Human Microbiome Market Size, by Product, 2019-2027 (USD Million)
Table 45. Global Human Microbiome Market Size, by Diagnostic Devices, 2019-2027 (USD Million)
Table 46. Global Human Microbiome Market Size, by Diagnostic Devices, by Region, 2019-2027 (USD Million)
Table 47. Global Human Microbiome Market Size, by Diagnostic Devices, by Region, 2019-2027 (USD Million)
Table 48. Global Human Microbiome Market Size, by Drugs, 2019-2027 (USD Million)
Table 49. Global Human Microbiome Market Size, by Drugs, by Region, 2019-2027 (USD Million)
Table 50. Global Human Microbiome Market Size, by Drugs, by Region, 2019-2027 (USD Million)
Table 51. Global Human Microbiome Market Size, by Foods, 2019-2027 (USD Million)
Table 52. Global Human Microbiome Market Size, by Foods, by Region, 2019-2027 (USD Million)
Table 53. Global Human Microbiome Market Size, by Foods, by Region, 2019-2027 (USD Million)
Table 54. Global Human Microbiome Market Size, by Prebiotic & Probiotics, 2019-2027 (USD Million)
Table 55. Global Human Microbiome Market Size, by Prebiotic & Probiotics, by Region, 2019-2027 (USD Million)
Table 56. Global Human Microbiome Market Size, by Prebiotic & Probiotics, by Region, 2019-2027 (USD Million)
Table 57. Global Human Microbiome Market Size, by Therapeutic Area, 2019-2027 (USD Million)
Table 58. Global Human Microbiome Market Size, by Gastrointestinal Disorders, 2019-2027 (USD Million)
Table 59. Global Human Microbiome Market Size, by Gastrointestinal Disorders, by Region, 2019-2027 (USD Million)
Table 60. Global Human Microbiome Market Size, by Gastrointestinal Disorders, by Region, 2019-2027 (USD Million)
Table 61. Global Human Microbiome Market Size, by Metabolic Disorders, 2019-2027 (USD Million)
Table 62. Global Human Microbiome Market Size, by Metabolic Disorders, by Region, 2019-2027 (USD Million)
Table 63. Global Human Microbiome Market Size, by Metabolic Disorders, by Region, 2019-2027 (USD Million)
Table 64. Global Human Microbiome Market Size, by Skin Disorders, 2019-2027 (USD Million)
Table 65. Global Human Microbiome Market Size, by Skin Disorders, by Region, 2019-2027 (USD Million)
Table 66. Global Human Microbiome Market Size, by Skin Disorders, by Region, 2019-2027 (USD Million)
Table 67. Global Human Microbiome Market Size, by Women’S Health, 2019-2027 (USD Million)
Table 68. Global Human Microbiome Market Size, by Women’S Health, by Region, 2019-2027 (USD Million)
Table 69. Global Human Microbiome Market Size, by Women’S Health, by Region, 2019-2027 (USD Million)
Table 70. Global Human Microbiome Market Size, by Application, 2019-2027 (USD Million)
Table 71. Global Human Microbiome Market Size, by Diagnostics, 2019-2027 (USD Million)
Table 72. Global Human Microbiome Market Size, by Diagnostics, by Region, 2019-2027 (USD Million)
Table 73. Global Human Microbiome Market Size, by Diagnostics, by Region, 2019-2027 (USD Million)
Table 74. Global Human Microbiome Market Size, by Therapeutics, 2019-2027 (USD Million)
Table 75. Global Human Microbiome Market Size, by Therapeutics, by Region, 2019-2027 (USD Million)
Table 76. Global Human Microbiome Market Size, by Therapeutics, by Region, 2019-2027 (USD Million)
Table 77. Global Human Microbiome Market: License & Pricing

Companies Mentioned

  • 4D pharma PLC
  • AOBiome, LLC
  • Astarte Medical Partners, Inc
  • Axial Therapeutics, Inc.
  • DuPont de Nemours, Inc.
  • Enterome Bioscience
  • Evelo Biosciences, Inc.
  • Exeliom Biosciences SAS
  • Ferring B.V.
  • Finch Therapeutics Group, Inc.
  • Intralytix, Inc.
  • Locus Biosciences, Inc.
  • Merck and Co. Inc.
  • Metabiomics Corporation
  • Osel Inc.
  • Second Genome, Inc.
  • Seres Therapeutics, Inc.
  • Synlogic, Inc.
  • Synthetic Biologics, Inc.
  • Vedanta Biosciences, Inc.
  • Yakult Honsha Co., Ltd.

Methodology

Loading
LOADING...